• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Access Reimbursement expansion positions

Quote

anonymous

Guest
With the launch of the new Alzheimer’s drug, there’s an expansion for access in Reimbursement positions. With those that are at the organization currently what are your thoughts with regards to the drugs approval in the expansion of these new positions?

Curious if they hire in June as I was told in the drug doesn’t come to market then what?
 
















anonymous said:
With the launch of the new Alzheimer’s drug, there’s an expansion for access in Reimbursement positions. With those that are at the organization currently what are your thoughts with regards to the drugs approval in the expansion of these new positions?

Curious if they hire in June as I was told in the drug doesn’t come to market then what?
Click to expand...

You’re toast then. If it comes to market at all, it’s got a Boxed warning and/or a REMS. Enjoy.
 












Does anyone know what the interview process consists of? I heard interview with hiring manager and then panel interview and then a couple more interviews after that. Has anyone made it that far?
 
























Top Bottom
Back
Quote